Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) Patients During Maintenance Therapy

被引：0
|
作者：
Ungaro, Ryan [1 ]
Jossen, Jacqueline [1 ]
Phan, Becky [2 ]
Chefitz, Ezra
Jain, Anjali [1 ,3 ]
Naik, Snehal [3 ]
Dubinsky, Marla [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol & Hepatol, New York, NY 10029 USA
[3] Prometheus Labs Inc, San Diego, CA USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PD-006
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] GOLIMUMAB DRUG LEVELS DURING MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Koduru, Pramoda
    Oglat, Ayah
    Abraham, Bincy P.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S52 - S52
  • [42] GOLIMUMAB DRUG LEVELS DURING MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Koduru, Pramoda
    Oglat, Ayah
    Abraham, Bincy P.
    GASTROENTEROLOGY, 2018, 154 (01) : S76 - S76
  • [43] CORRELATION OF VEDOLIZUMAB TROUGH LEVELS WITH CLINICAL AND BIOCHEMICAL MARKERS IN INFLAMMATORY BOWEL DISEASE
    Tamilarasan, Aravind Gokul
    Guerrero, Antonio
    Arias, Laura
    Burns, Megan
    Arkir, Zehra
    Irving, Peter
    GUT, 2019, 68 : A98 - A99
  • [44] VEDOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: UPDATED INITIAL EXPERIENCE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang
    Raffals, Laura
    Tremaine, William J.
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S62 - S63
  • [45] Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease
    Yacoub, W.
    Williet, N.
    Pouillon, L.
    Di-Bernado, T.
    Bittencourt, M. De Carvalho
    Nancey, S.
    Lopez, A.
    Paul, S.
    Zallot, C.
    Roblin, X.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S334 - S334
  • [46] VEDOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: UPDATED INITIAL EXPERIENCE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang
    Raffals, Laura
    Tremaine, William J.
    Loftus, Edward V., Jr.
    GASTROENTEROLOGY, 2018, 154 (01) : S89 - S89
  • [47] Infliximab trough levels during maintenance are predictive for infliximab efficacy in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Hoffman, I.
    Dreesen, E.
    Ferrante, M.
    Gils, A.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S180 - S181
  • [48] High infliximab trough levels are associated with impaired quality of life in IBD patients in clinical and biochemical remission on maintenance IFX therapy
    Lowenberg, M.
    Brandse, J.
    Vos, L.
    Ponsioen, C.
    van den Brink, G.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S262 - S263
  • [49] High Infliximab Trough Levels Are Associated With Impaired Quality of Life in IBD Patients in Clinical and Biochemical Remission on Maintenance IFX Therapy
    Lowenberg, M.
    Brandse, Johannan F.
    Vos, Laura M.
    Ponsioen, Cyriel
    van den Brink, Gijs R.
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2014, 146 (05) : S450 - S450
  • [50] Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study
    Martin, Antoine
    Nachury, Maria
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Nancey, Stephane
    Bourrier, Anne
    Serrero, Melanie
    Fumery, Mathurin
    Buisson, Anthony
    Laharie, David
    Gilletta, Cyrielle
    Filippi, Jerome
    Allez, Matthieu
    Bouguen, Guillaume
    Roblin, Xavier
    Altwegg, Romain
    Dib, Nina
    de Chambrun, Guillaume Pineton
    Savoye, Guillaume
    Carbonnel, Franck
    Viennot, Stephanie
    Amiot, Aurelien
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 896 - 903
12345